66 reports

  • HEART FAILURE DRUGS MARKET IN AMERICAS
  • HEART FAILURE DRUGS MARKET IN APAC

About Heart Failure Drugs The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major...

  • Beta-Blocker
  • Heart Failure
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG
  • 2 Heart Failure: Executive Summary
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Heart Failure - Epidemiology Forecasts to 2026 Summary Heart failure (HF), also referred to as congestive cardiac failure, is a heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic needs of the body (AHA, 2015a). HF commonly occurs in people older than...

  • Heart Failure
  • Hospital
  • United States
  • Forecast
  • American Heart Association, Inc.

Global Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017 ##.

  • Heart Failure
  • France
  • United States
  • World
  • Forecast
  • NYHA Classification of Heart Failure
  • Aetiologies of Heart Failure

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Chronic Heart Failure in 12 Major Markets Chronic heart failure (CHF) is a chronic disease during which the heart is not able to supply sufficient blood flow to the body. Exacerbations of CHF are characterised by dyspnoea at rest or on exertion and...

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • Pathology

Europe Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017 ##.

  • Heart Failure
  • Europe
  • France
  • Germany
  • Italy

Acute Heart failure (AHF) -Epidemiology Forecast to 2027 ##.

  • Heart Failure
  • France
  • Germany
  • Italy
  • Spain

Acute Heart failure (AHF) - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Chronic Disease
  • Heart Failure
  • United States
  • Market Shares
  • 12.8.5 BUSINESS STRATEGY
  • DATE

The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for...

  • Heart Failure
  • World
  • Market Size
  • Abiomed, Inc.
  • Medtronic, Inc.
  • FOCUS ON UNMET NEEDS FOR ADVANCED HEART FAILURE
  • HOSPITAL ADMISSION FOR CONGESTIVE HEART FAILURE PER 100,000 INDIVIDUALS IN FEW COUNTRIES IN EMEA 2008 AND 2013

About VADs VADs are of three types — LVADs, BiVADs, and RVADs — that are used to treat heart failure. VADs help the weakened heart to pump blood for circulation to other body organs. Surgeons implant these mechanical devices as a treatment option for severe heart conditions such as acute or chronic cardiac functional deterioration and...

  • Heart Failure
  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • Thoratec Corporation
  • 11.7.4 KEY DEVELOPMENTS
  • ACQUISITIONS (2015-2017)

The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure....

  • Heart Failure
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Acquisitions
  • MEDTRONIC: COMPANY SNAPSHOT (2016)

The heart pump devices market is projected to grow at a CAGR of 19.4% The global heart pump devices market is projected to reach USD 3.98 billion by 2022 from an estimated USD 1.64 billion in 2017, at a CAGR of 19.4% during the forecast period. Rising prevalence of cardiovascular diseases, increasing number of regulatory...

  • Heart Failure
  • North America
  • United States
  • Abiomed, Inc.
  • Impella CardioSystems AG
  • TREATMENT ALTERNATIVES FOR HEART FAILURE
  • 2.1 HEART FAILURE: AN OVERVIEW

Scope of the Report The report entitled “Global Mechanical Circulatory Support (MCS) Market with Focus on the Ventricular Assist Device (VAD) (2016-2020)”, provides analysis of the global MCS market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes...

  • Heart Failure
  • HeartWare International, Inc.
  • Jude Medical, Inc.
  • ReliantHeart
  • Thoratec Corporation
  • SAPIEN 3 HEART VALVE - HEART FAILURE
  • SAPIEN 3 HEART VALVE - HEART FAILURE

Summary Edwards Lifesciences Corp (Edwards) is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring.It develops and commercializes heart valve products such as heart...

  • Heart Failure
  • Prosthesis
  • United States
  • Edwards Lifesciences Corporation
  • Valtech Cardio, Ltd.
  • IMPLEMENTATION OF MINIMALLY INVASIVE PROCEDURES

About Cardiac Resynchronization Therapy-pacemaker (CRT-P) CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness...

  • Heart Failure
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • LivaNova PLC
  • Medtronic, Inc.

How confident are you that LCZ##' s benefit will translate into heart failure patients with preserved ejection fraction?

  • Cardiovascular Drug
  • Heart Failure
  • Therapy
  • United States
  • Supply
  • REVENUE OF GLOBAL BTR THERAPY IN LVAD MARKET 2015-2020 ($ MILLIONS)
  • IMPACT OF DRIVERS AND CHALLENGES

About the Left Ventricular Assist Device (LVAD) Market LVADs supplement the pumping of blood by weak hearts. Surgeons implant this mechanical device as a treatment option for severe heart conditions such as acute or chronic deterioration of cardiac functions and heart failure. Surgeons also use the device for BTT, BTR, BTD, and destination...

  • Heart Failure
  • World
  • Abiomed, Inc.
  • Jarvik Heart, Inc.
  • Jude Medical, Inc.
  • LATEST CLINICAL TRIALS NEWS ON CONGESTIVE HEART FAILURE (HEART FAILURE)
  • The US has the highest number of congestive heart failure (heart failure) clinical trials, as of June 2017.

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides...

  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Trial
  • Heart Failure
  • World
  • DIASTOLIC HEART FAILURE THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • DIASTOLIC HEART FAILURE THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*

Diastolic Heart Failure Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H2, 2017" provides an overview of Diastolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on...

  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.
  • Latest Clinical Trials News on Acute Heart Failure
  • ACUTE HEART FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2017*

Acute Heart Failure Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H1, 2017” provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart...

  • Clinical Trial
  • Heart Failure
  • World
  • Product Initiative
  • Novartis AG

One of the major drivers is increasing the incidence of cardiac disorders.

  • Heart Failure
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2018, provides an overview of the Congestive Heart Failure (Heart Failure)...

  • Gene Therapy
  • Heart Failure
  • United States
  • Company
  • Product Initiative
  • Latest Clinical Trials News on Acute Heart Failure
  • Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Acute Heart Failure Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2016" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure....

  • Drug Discovery And Development
  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • CONGESTIVE HEART FAILURE (HEART FAILURE)
  • CONGESTIVE HEART FAILURE (HEART FAILURE)

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline...

  • Gene Therapy
  • Heart Failure
  • United States
  • Company
  • Product Initiative
  • REASONS FOR DISCONTINUATION
  • CICLOMULSION LATE-PHASE TRIAL DATA IN ACUTE CORONARY SYNDROME

The $1.9bn acute coronary syndrome (ACS) market will experience moderate growth over the forecast period, driven by uptake of Brilinta and Xarelto in the secondary-prevention setting. This report addresses the following questions: - How will the updated 2016 treatment guidelines impact the use of new antiplatelet agents...

  • Heart Failure
  • United States
  • AstraZeneca PLC
  • NSTEMI group
  • The Medicines Company
  • Acute Heart Failure Overview
  • Acute Heart Failure - Dormant Projects

Acute Heart Failure - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Acute Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Heart Failure, complete...

  • Heart Failure
  • Therapy
  • United States
  • World
  • Product Initiative
  • Latest Clinical Trials News on Congestive Heart Failure (Heart Failure)
  • Clinical Trials by E7 Countries: Proportion of Congestive Heart Failure (Heart Failure) to Cardiovascular Clinical Trials

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides...

  • Cardiovascular Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Heart Failure
  • World
  • Systolic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Systolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2015*

Systolic Heart Failure Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Systolic Heart Failure Global Clinical Trials Review, H2, 2015" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic...

  • Cardiovascular Disease
  • Heart Failure
  • Therapy
  • World
  • Product Initiative
  • EPIDEMIOLOGIC TRANSITION OF CV DISEASES

About ACS ACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and short-term mortality. On the basis of evidence of heart muscle damage and changes in the ST-tracing of the ECG, ACS is classified...

  • Heart Failure
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Acute Heart Failure Overview
  • Acute Heart Failure - Therapeutics Assessment

Acute Heart Failure - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Acute Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Heart Failure, complete...

  • Heart Failure
  • Research And Development
  • United States
  • Company Operations
  • Product Initiative
  • DIASTOLIC HEART FAILURE
  • Unaccomplished Trials of Diastolic Heart Failure

Diastolic Heart Failure Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diastolic Heart Failure Global Clinical Trials Review, H1, 2015" provides data on the Diastolic Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical...

  • Heart Failure
  • United States
  • World
  • Market Size
  • Product Initiative